It blocks the action of a certain substance that may be needed for cancer cell multiplication.
How should Gefitinib be used:
It comes as a tablet to take by mouth, with or without food. The recommended daily dose is one 250 mg.
Common side effects of Gefitinib :
Diarrhea, rash, pimples, dry skin, nausea, vomiting, itching, loss of appetite, weakness and weight loss.
What do I do if I miss a dose
Take a missed dose as soon as you think about it. If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not take 2 doses at the same time or extra doses
What precautions should I take when taking Gefitinib :
If you have an allergy to gefitinib or any other part of this drug. Tell your doctor if you are allergic to any drugs. Make sure to tell about the allergy and what signs you had. This includes telling about rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you are pregnant or may be pregnant. If you are breast-feeding.
When do I need to seek medical help
If you think there was an overdose, call your local poison control center or ER right away. Signs of a very bad reaction to the drug. These include wheezing; chest tightness; fever; itching; bad cough; blue or gray skin color; seizures; or swelling of face, lips, tongue, or throat. Trouble breathing. Very upset stomach or throwing up. Very loose stools (diarrhea). A big weight loss. Any bruising or bleeding. Dark urine or yellow skin or eyes. Feeling very tired or weak. Sudden change in eyesight, eye pain, or irritation. Very bad swelling. Any rash.
Can I take Gefitinib with other medicines:
Sometimes drugs are not safe when you take them with certain other drugs and food. – Taking them together can cause bad side effects. – Be sure to talk to your doctor about all the drugs you take.
Are there any food restrictions
How do I store Gefitinib :
Store in a cool, dry place away from the reach of children. – Medicines must not be used past the expiry date.
Category D : There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.